Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
0.4805
+0.0229 (5.00%)
At close: Aug 24, 2026, 4:00 PM EDT
0.4724
-0.0081 (-1.69%)
After-hours: Aug 24, 2026, 4:20 PM EDT
Arcadia Biosciences Revenue
Arcadia Biosciences had revenue of $1.44M in the quarter ending June 30, 2026, a decrease of -0.82%. This brings the company's revenue in the last twelve months to $4.75M, down -12.24% year-over-year. In the year 2025, Arcadia Biosciences had annual revenue of $4.86M, down -3.71%.
Revenue (ttm)
$4.75M
Revenue Growth
-12.24%
P/S Ratio
0.22
Revenue / Employee
$593,250
Employees
8
Market Cap
1.16M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.86M | -187.00K | -3.71% |
| Dec 31, 2024 | 5.05M | 591.00K | 13.27% |
| Dec 31, 2023 | 4.45M | -2.96M | -39.96% |
| Dec 31, 2022 | 7.42M | 638.00K | 9.41% |
| Dec 31, 2021 | 6.78M | -1.25M | -15.61% |
| Dec 31, 2020 | 8.03M | 6.87M | 587.25% |
| Dec 31, 2019 | 1.17M | -295.00K | -20.15% |
| Dec 31, 2018 | 1.46M | -2.56M | -63.64% |
| Dec 31, 2017 | 4.03M | 838.00K | 26.29% |
| Dec 31, 2016 | 3.19M | -2.23M | -41.12% |
| Dec 31, 2015 | 5.41M | -1.57M | -22.46% |
| Dec 31, 2014 | 6.98M | 504.00K | 7.78% |
| Dec 31, 2013 | 6.48M | -532.00K | -7.59% |
| Dec 31, 2012 | 7.01M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Natural Alternatives International | 141.87M |
| Wing Yip Food Holdings Group | 132.98M |
| Coffee Holding Co. | 99.35M |
| DDC Enterprise | 39.18M |
| Australian Oilseeds Holdings | 29.23M |
| Farmmi | 27.97M |
| Paranovus Entertainment Technology | 14.60M |
| SRX Global | 12.78M |
RKDA News
- 11 days ago - Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights - GlobeNewsWire
- 11 days ago - Arcadia Biosciences Quarterly report: Q2 2026 - Filings
- 11 days ago - Arcadia Biosciences Earnings release: Q2 2026 - Filings
- 14 days ago - Arcadia Biosciences Proxy statement: Proxy filing - Filings
- 24 days ago - Arcadia Biosciences Proxy statement: Proxy filing - Filings
- 2 months ago - Arcadia Biosciences files to sell 11.92M shares of common stock for holders - TheFly
- 2 months ago - Arcadia Biosciences Registration statement: Registration filing - Filings
- 2 months ago - Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire